As demonstrated by Mhillaj et al. [150], celecoxib (1–10 μM), namely at concentrations which resemble those found in the AD brain after therapeutic doses, increased HO-1 expression in SH-SY5Y neurons exposed to either soluble or fibrillary Aβ [150]. The gene discussed is HMOX1; the disease is Alzheimer disease.